Literature DB >> 32504812

Big Data-driven personal protective equipment stockpiling framework under Universal Healthcare for Disease Control and Prevention in the COVID-19 Era.

Kevin Sheng-Kai Ma1, Shin-Yi Tsai2.   

Abstract

Entities:  

Keywords:  Coronavirus pandemic; Epidemic prevention policies; Personal protective equipment; Universal healthcare systems

Mesh:

Year:  2020        PMID: 32504812      PMCID: PMC7270797          DOI: 10.1016/j.ijsu.2020.05.091

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


× No keyword cloud information.
To the editor: We read with great interest the article by Tang et al. on avoiding iatrogenic infection [1]. In this letter we reported Taiwan's experience using big data analytics platforms designed to allow PPE providers to manage the distribution of surgical masks on a real-time basis, and to identify mask holders. Big data analytics has improved healthcare by analyzing electronic medical records, socio-demographic information, and environmental factors [2]; moreover, its tracking roles in emerging infectious diseases including the coronavirus pandemic have been discussed [3]. In countries with single-payer universal healthcare systems (UHS), claimed data of payers could be an abundant source for analytics. On the other hand, compulsory social distancing, coupled with mass masking, has been widely adopted as strategy for non-specific symptoms at early stage COVID-19 [4]. We propose that analytics based on proper concatenation of databases may prevent supply shortages for personal protective equipment (PPEs). Taking Taiwan as an example, cloud computing-based healthcare databases within the UHS has alleviated the integration between primary care providers and hospitals, as well as reduced the cost of tracking procedure. Applying the same logistics to PPE allocation would allow PPE providers to manage the distribution of surgical masks on a real-time basis, and recognize the mask holders per insurance or passport number [5]. With the help of data analysis, combining artificial intelligence and cloud technology, public health policy-making could be practicable. Thus when it comes to the implementation cost of epidemic prevention policies, Taiwan authorities adopt low stringent level strategies compared with other high income countries, but still have achieved epidemic control in the early outbreak [6]. After the 2003 severe acute respiratory syndrome outbreak, Taiwan CDC (TCDC) started transferring registered real-time infectious disease data to this established monitoring system, where PPE stockpiling platform was practiced. Therefore, prior to the official recognition of COVID-19 outbreak [3], PPE databases were subsequently concatenated by UHS to manage resource allocation and logistics when several cases were identified. Establishment of this application programming interface for mask-selling pharmacies under UHS required data transfers as well as managerial issues including governance and ownership, which interdepartmental communication was efficient within UHS. Specifically, the tracking system expands the healthcare informatics system that pharmacists are familiar with, which user friendly interfaces for these PPE providers and consumers help expedite processes in an efficient manner [5]. UHS and TCDC have also promoted the system to increase the distribution channels, which government offices may also allot masks to lessen the burden on healthcare providers. Since masks alone aren't effective without combining infection-control measures [7], we recommend to utilize such integrative platform for the maintenance of more PPE stockpiles, including critical infection-control equipments, so as to reduce iatrogenic COVID-19 exposure. Provenance and peer review- Not Commissioned, internally reviewed.

Data statement

All data are from open access sources and can be shared on request.

Ethical approval

NA.

Funding

NA.

Author contribution

Kevin Sheng-Kai Ma: Conceptualization, data analysis, writing - original draft and editing. Shin-Yi Tsai: Conceptualization, discussion, and review.

Research registration Unique Identifying number (UIN)

1. Name of the registry: NA. 2. Unique Identifying number or registration ID: NA. 3. Hyperlink to your specific registration (must be publicly accessible and will be checked): NA.

Guarantor

Shin-Yi Tsai, MD, DrPH.

Declaration of competing interest

The authors declare no conflict of interest.
  7 in total

1.  Nutritional support for successful weaning in patients undergoing prolonged mechanical ventilation.

Authors:  Hsing-Chun Lin; Shun-Fa Yang; Shih-Ching Lo; Kevin Sheng-Kai Ma; Yen-Ru Li; Zi-Yue Li; Cheng-Hung Lin
Journal:  Sci Rep       Date:  2022-07-14       Impact factor: 4.996

2.  Risk of Autoimmune Diseases Following Optic Neuritis: A Nationwide Population-Based Cohort Study.

Authors:  Kevin Sheng-Kai Ma; Chee-Ming Lee; Po-Hung Chen; Yan Yang; Yi Wei Dong; Yu-Hsun Wang; James Cheng-Chung Wei; Wen Jie Zheng
Journal:  Front Med (Lausanne)       Date:  2022-06-13

3.  Big data driven COVID-19 pandemic crisis management: potential approach for global health.

Authors:  Yang Lv; Chenwei Ma; Xiaohan Li; Min Wu
Journal:  Arch Med Sci       Date:  2021-03-20       Impact factor: 3.318

4.  Bidirectional Relationship Between Osteoarthritis and Periodontitis: A Population-Based Cohort Study Over a 15-year Follow-Up.

Authors:  Kevin Sheng-Kai Ma; Jung-Nien Lai; Eshwar Thota; Hei-Tung Yip; Ning-Chien Chin; James Cheng-Chung Wei; Thomas E Van Dyke
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

5.  Risk of primary Sjogren's Syndrome following human papillomavirus infections: a nationwide population-based cohort study.

Authors:  Huang-Hsi Chen; Kevin Sheng-Kai Ma; Chen Dong; Wen-Jung Chang; Kuan-Rong Gao; Wuu-Tsun Perng; Jing-Yang Huang; James Cheng-Chung Wei
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

Review 6.  Madness of the crowd: Understanding mass behaviors through a multidisciplinary lens.

Authors:  Emily Brindal; Naomi Kakoschke; Andrew Reeson; David Evans
Journal:  Front Psychol       Date:  2022-08-19

Review 7.  Safety and Seroconversion of Immunotherapies against SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis of Clinical Trials.

Authors:  Kevin Sheng-Kai Ma; Chien-Chang Lee; Ko-Jiunn Liu; James Cheng-Chung Wei; Yuan-Ti Lee; Li-Tzu Wang
Journal:  Pathogens       Date:  2021-11-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.